Moreno, Marķa <br/><br/>
Toll-like receptor agonists and invariant natural killer T-cells enhance antibody-dependent cell-mediated cytotoxicity (ADCC).  [electronic resource] 

 -  Cancer letters  Dec 2008 
 - 70-6 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1872-7980 
<br/><br/><label>Standard No.: </label>10.1016/j.canlet.2008.06.028  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal--immunology<br/>Antibody-Dependent Cell Cytotoxicity--immunology<br/>Antigens, CD--immunology<br/>Antigens, Differentiation, T-Lymphocyte--immunology<br/>Flow Cytometry<br/>Granzymes--immunology<br/>Humans<br/>Immunoglobulin G--pharmacology<br/>Immunotherapy--methods<br/>Killer Cells, Natural--immunology<br/>Lectins, C-Type<br/>Leukocytes, Mononuclear--immunology<br/>Lymphocyte Activation<br/>Mice<br/>Mucin-1--immunology<br/>Natural Killer T-Cells--immunology<br/>Toll-Like Receptors--immunology